Valexfarm Report issue

For profit Phase 3
Founded: Belgrade Serbia (1997)
Status: No NME R&D (1997)

Organization Overview

First Clinical Trial
2009
NCT01179854
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

calcium carbonate (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Epilepsies, Partial (Phase 3)

Seizures (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1